ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
SOTIO Presents New Data Showing Strong Anti-tumor Effect of IL-15 Superagonist SO-C101 in Mice at 2020 AACR Virtual Annual Meeting II
July 01, 2020SOTIO and Cytune Pharma from the PPF Group, today presented new preclinical data highlighting the therapeutic potential of SO-C101, an IL-15 superagonist, as a monotherapy and in combination with PD-1 inhibitors in multiple tumor models. -
SOTIO Initiates First-In-Human Clinical Trial with IL-15 Superagonist SO-C101
July 12, 2019SOTIO and Cytune Pharma, members of the PPF Group, announce today the first dosing of cancer patients with SO-C101, a superagonist fusion protein of interleukin IL-15.
Pharma Sources Insight January 2025
